243
+0.41%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥25.40bn
FY2017FY2026
Net income
−¥434.9m
FY2017FY2026
Free cash flow
¥405.7m
FY2017FY2026
Shareholders' equity
¥10.46bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥25.40bn | ¥25.89bn | ¥26.47bn | ¥25.45bn | ¥24.15bn | ¥22.80bn | ¥22.84bn | ¥22.41bn | ¥20.20bn | ¥17.74bn |
| Gross profit | ¥6.80bn | ¥6.92bn | ¥7.18bn | ¥6.68bn | ¥7.12bn | ¥6.00bn | ¥5.84bn | ¥5.64bn | ¥5.26bn | ¥4.99bn |
| Research and development | — | ¥446.2m | ¥369.3m | ¥318.0m | ¥278.5m | ¥258.7m | ¥257.0m | ¥192.3m | ¥190.1m | ¥149.1m |
| Operating income | ¥599.8m | ¥895.6m | ¥1.40bn | ¥1.36bn | ¥2.01bn | ¥1.22bn | ¥1.10bn | ¥1.12bn | ¥954.7m | ¥739.7m |
| Net income | −¥434.9m | ¥543.8m | ¥969.9m | ¥870.0m | ¥1.61bn | ¥632.4m | ¥270.3m | ¥699.8m | ¥680.3m | ¥429.4m |
| Diluted earnings per share | -14.40 | 18.00 | 32.11 | 28.80 | 53.44 | 21.00 | 9.01 | 23.40 | 22.75 | 14.36 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥24.56bn | ¥25.55bn | ¥26.52bn | ¥25.56bn | ¥23.73bn | ¥23.79bn | ¥22.14bn | ¥23.14bn | ¥22.56bn | ¥21.63bn |
| Cash and short-term investments | ¥5.11bn | ¥5.12bn | ¥5.35bn | ¥4.63bn | ¥5.17bn | ¥4.55bn | ¥3.43bn | ¥5.13bn | ¥5.49bn | ¥5.79bn |
| Total liabilities | ¥14.07bn | ¥14.33bn | ¥15.49bn | ¥15.13bn | ¥13.77bn | ¥14.98bn | ¥13.82bn | ¥14.42bn | ¥14.22bn | ¥13.85bn |
| Debt | ¥5.59bn | ¥5.59bn | ¥6.16bn | ¥5.92bn | ¥4.61bn | ¥5.58bn | ¥5.41bn | ¥5.62bn | ¥6.19bn | ¥6.85bn |
| Shareholders' equity | ¥10.46bn | ¥11.20bn | ¥10.98bn | ¥10.39bn | ¥9.91bn | ¥8.79bn | ¥8.29bn | ¥8.67bn | ¥8.33bn | ¥7.77bn |
| Shares outstanding | 30m | 30m | 30m | 30m | 30m | 30m | 30m | 30m | 30m | 30m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥1.15bn | ¥1.71bn | ¥2.11bn | −¥637.9m | ¥2.31bn | ¥2.13bn | −¥135.1m | ¥774.2m | ¥1.85bn | ¥217.8m |
| Capital spending | −¥740.8m | −¥754.3m | −¥1.11bn | −¥914.9m | −¥605.2m | −¥555.0m | −¥1.03bn | −¥256.2m | −¥506.2m | −¥273.8m |
| Free cash flow | ¥405.7m | ¥951.2m | ¥1.01bn | −¥1.55bn | ¥1.70bn | ¥1.58bn | −¥1.17bn | ¥518.0m | ¥1.34bn | −¥56.0m |
| Dividends paid | −¥391.2m | −¥391.1m | −¥390.6m | −¥421.0m | −¥299.7m | −¥299.0m | −¥299.1m | −¥269.5m | −¥239.5m | −¥299.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥5.74bn | ¥7.89bn | ¥6.71bn | ¥5.64bn | ¥5.16bn | ¥7.40bn | ¥6.64bn | ¥6.20bn |
| Gross profit | ¥1.57bn | ¥2.08bn | ¥1.73bn | ¥1.57bn | ¥1.41bn | ¥1.86bn | ¥1.82bn | ¥1.76bn |
| Operating income | ¥26.3m | ¥417.8m | ¥221.2m | ¥46.0m | −¥85.3m | ¥234.5m | ¥326.4m | ¥308.2m |
| Net income | ¥10.3m | −¥492.1m | ¥114.0m | ¥15.5m | −¥72.4m | ¥165.7m | ¥193.9m | ¥217.8m |
| Diluted earnings per share | 0.34 | -16.29 | 3.77 | 0.51 | -2.40 | 5.49 | 6.42 | 7.21 |
| Total assets | ¥23.02bn | ¥24.56bn | ¥24.62bn | ¥23.16bn | ¥23.80bn | ¥25.55bn | ¥25.58bn | ¥24.40bn |
| Cash and short-term investments | ¥4.93bn | ¥5.11bn | ¥4.15bn | ¥3.95bn | ¥4.08bn | ¥5.12bn | ¥4.81bn | ¥4.19bn |
| Debt | ¥1.53bn | ¥5.33bn | ¥2.06bn | ¥4.50bn | ¥1.59bn | ¥5.30bn | ¥1.99bn | ¥5.08bn |
| Shareholders' equity | ¥10.11bn | ¥10.46bn | ¥10.91bn | ¥10.77bn | ¥10.73bn | ¥11.20bn | ¥10.98bn | ¥10.78bn |
Financial ratios
Data as of 7 Oct 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 26.8% | 26.7% | 27.1% | 26.2% | 29.5% | 26.3% | — |
| Operating margin | 2.4% | 3.3% | 5.2% | 5.3% | 8.2% | 5.2% | — |
| Net margin | -1.7% | 2.1% | 3.7% | 3.4% | 6.7% | 2.8% | — |
| Return on equity | -4.2% | 4.9% | 8.8% | 8.4% | 16.3% | 7.2% | — |
| Return on assets | -1.8% | 2.1% | 3.7% | 3.4% | 6.8% | 2.7% | — |
| Free cash flow yield | 23.4% | 30.5% | 39.9% | 3.4% | 36.1% | 33.5% | — |
| Revenue growth | -1.9% | -2.2% | 4.0% | 5.4% | 5.9% | -0.2% | — |
| Earnings growth | -180.0% | -43.9% | 11.5% | -46.1% | 155.3% | 134.0% | — |
| Current ratio | 1.77x | 1.77x | 1.78x | 1.72x | 1.64x | 1.50x | — |
| Debt to equity | 0.51x | 0.47x | 0.53x | 0.53x | 0.43x | 0.59x | — |
| Equity ratio | 42.6% | 43.8% | 41.4% | 40.6% | 41.8% | 36.9% | — |
| Interest coverage | 10.31x | 18.39x | 42.19x | 47.78x | 73.35x | 39.25x | — |
| R&D as a share of sales | — | 1.7% | 1.4% | 1.2% | 1.2% | 1.1% | 1.1% |
| Buybacks as a share of market value | 0.0% | 0.0% | 0.0% | 0.0% | -0.3% | -0.3% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -0.1% | 2.2% | 2.7% |
| Operating income | -24.0% | -13.2% | 1.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 26.7% | 26.7% | 27.1% | 26.6% |
| Operating margin | 2.9% | 4.1% | 5.0% | 4.7% |
| Net margin | 0.2% | 1.9% | 2.8% | 2.6% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -17.9 | 14.8 | 8.4 | 11.3 | 5.6 | 18.1 | 31.2 | 15.5 | 12.3 | 21.1 |
| Price to sales | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.4 | 0.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 31 years. Last went ex-dividend on 30 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 26.00 | 13.00 | 13.00 | 14.00 | 10.00 | 10.00 | 10.00 | 8.00 |
- 2-for-1 split · 26 Sept 2018
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.